AEON Biopharma AEON
NYSE AEON
$0.23 +0.00 (+1.26%)
As of: Oct 20, 2026 · 3:59 PM EDT

AEON Biopharma (AEON) EV to EBIT (2024 - 2025)

Updated

AEON Biopharma's EV to EBIT came in at -0.06 for Q1 2025.

Analysis

AEON Biopharma (AEON) EV to EBIT (2024 - 2025) Analysis & Trends

Over the trailing twelve months to Mar 31, 2025, AEON Biopharma reported EV to EBIT of -0.08; for FY2024, it came in at 0.29.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 AEON Biopharma 11.93 Mn -8.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -0.06
Dec 31, 2024 0.29
API Access

AEON Biopharma EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AEON&period=max&api_key=YOUR_API_KEY